ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NUVA Nuvasive Inc

39.75
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nuvasive Inc NASDAQ:NUVA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 39.75 36.36 42.00 0 01:00:00

Form 15-12G - Securities registration termination [Section 12(g)]

11/09/2023 9:46pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

NUVASIVE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   000-50744   33-0768598
(State or other jurisdiction of
incorporation or organization)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

12101 Airport Way

Broomfield, CO 80021

(800) 455-1476

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

      

Rule 12g-4(a)(2)

      

Rule 12h-3(b)(1)(i)

      

Rule 12h-3(b)(1)(ii)

      

Rule 15d-6

      

Rule 15d-22(b)

      

Approximate number of holders of record as of the certification or notice date: 1*

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: September 11, 2023

 

NUVASIVE, INC.
By:  

/s/ Daniel T. Scavilla

  Name: Daniel T. Scavilla
  Title: President and Chief Executive Officer

 

*

On September 1, 2023, pursuant to the Agreement and Plan of Merger, dated February 8, 2023, by and among NuVasive, Inc. (the “Registrant”), Globus Medical, Inc., a Delaware corporation (“Globus Medical”), and Zebra Merger Sub, Inc., a wholly owned subsidiary of Globus Medical (“Merger Sub”), Merger Sub merged with and into the Registrant, with the Registrant continuing as the surviving corporation and as a wholly owned subsidiary of Globus Medical.

 

 

 


1 Year Nuvasive Chart

1 Year Nuvasive Chart

1 Month Nuvasive Chart

1 Month Nuvasive Chart

Your Recent History

Delayed Upgrade Clock